Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Henan Cancer Hospital
Institut Paoli-Calmettes
University Hospital Ostrava
Radiotherapy Oncology Centre "Santa Maria" Hospital
Fondazione IRCCS Policlinico San Matteo di Pavia
The First Hospital of Jilin University
Tianjin Medical University Cancer Institute and Hospital
National Cancer Institute, Naples
Sykehuset i Vestfold HF
Henan Provincial People's Hospital
Fuzhou General Hospital
Second Xiangya Hospital of Central South University
Qilu Hospital of Shandong University
The First Affiliated Hospital of Henan University of Science and Technology
The Second Affiliated Hospital of Shandong First Medical University
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Tang-Du Hospital
Betta Pharmaceuticals Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Beijing Chest Hospital
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Peking Union Medical College Hospital
Qilu Pharmaceutical Co., Ltd.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Nanfang Hospital, Southern Medical University
ChineseAMS
Ain Shams University
Shanghai Pulmonary Hospital, Shanghai, China
The First People's Hospital of Lianyungang
The First Affiliated Hospital of Dalian Medical University
SciClone Pharmaceuticals
Shanghai International Medical Center
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Hunan Province Tumor Hospital
Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd.
Zhejiang University
National Cancer Institute (NCI)
ChineseAMS
National Cancer Center, Korea
National Cancer Institute (NCI)